Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial

Area of Science:

• Cardiovascular Medicine
• Traditional Chinese Medicine
• Endocrinology

Background:

• Cardiovascular disease (CVD) poses a significant global health challenge.
• Berberine, a traditional Chinese medicine, shows promise for managing CVD risk factors.
• Its effects and mechanisms in men, particularly concerning testosterone, remain under-explored.

Purpose of the Study:

• To investigate the impact of berberine on cardiovascular disease risk factors in men.
• To examine the potential influence of berberine on testosterone levels in men.
• To assess berberine's efficacy and safety in Chinese men with hyperlipidemia.

Main Methods:

• A 12-week, randomized, double-blind, placebo-controlled trial involving 84 Chinese men with hyperlipidemia.
• Participants received either berberine (500 mg twice daily) or a placebo.
• Cardiovascular risk factors and testosterone levels were measured at baseline, 8 weeks, and 12 weeks.

Main Results:

• Berberine significantly reduced total cholesterol and high-density lipoprotein cholesterol levels after 12 weeks.
• The intervention showed a potential decrease in low-density lipoprotein cholesterol and an increase in testosterone.
• No significant differences were observed in triglycerides, thromboxane A2, blood pressure, or body composition between groups.

Conclusions:

• Berberine demonstrates potential as a cholesterol-lowering agent in men.
• Contrary to concerns, berberine may increase testosterone levels in men, suggesting sex-specific effects.
• Further research into berberine's pathways and sex differences is warranted for potential drug repositioning.